![](https://ce.horizoncme.com/sites/default/files/styles/course_image/public/media/2022-08/Cells-CV.jpg?itok=QWHV0Puc)
Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers (Virtual Conference) Fall 2024
- This conference will be a virtual (online) event. -
Overview
The demand for cancer care is expected to increase by 40% over the next six years; however, ASCO is projecting a shortage of more than 2,200 oncologists by 2025. To meet the cancer care needs of all patients, advanced practice providers (APPs), whose education and training focus on health promotion, disease prevention, and primary care medical management, have been increasingly sought-after to fill this shortage. However, many new APPs have little background and training in oncology. As a result, oncology practices need to provide new staff with an onboarding program to help further their knowledge of hematology and oncology.
To assist APPs in their new careers in oncology-based practices, Horizon CME, in partnership with APAO, has developed “Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers.” In this two-and-a-half-day virtual program, clinicians will gain a greater understanding of cancer treatment, cancer therapies, side effects, supportive care strategies, palliative care, and more. Expert faculty will provide a detailed review of treatment strategies for hematologic disorders and solid malignancies. Participation in the program will allow APPs to build upon the foundational knowledge acquired in Oncology 101 and provide APPs with a deeper understanding of the cancer treatment strategies they need to support and care for cancer patients as part of the multidisciplinary oncology care team.
This program is appropriate for nurse practitioners, physician assistants, nurses, and pharmacists in hematology/oncology seeking an in-depth review of cancer treatment strategies and therapies.
Registration | Pricing | Deadline |
Early Bird | $100 | July 24, 2024 |
Advanced | $125 | September 24, 2024 |
General Registration | $150 | October 24, 2024 |
Student/Fellows* | $25 |
|
Industry Employee** registration is date based pricing +$300
*Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession.
If you would like to attend as a Student, please contact info@horizoncme.com for further information.
**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc).
Learning Objectives.
- Outline strategies for the treatment of common solid and hematologic malignancies
- Summarize the role of genetics and molecular testing in cancer care
- Implement palliative care and pain management strategies for patients with cancer
- Discuss strategies for the administration and management of chemotherapy
- Identify and appropriately manage immune-related adverse events
- Recognize and treat the adverse effects associated with radiation oncology
Target Audience
This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.
Presented By In Partnership with
Commercial Support: Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers (Virtual Conference) Fall 2024 is supported in part by independent medical educational grants from Merck Sharp & Dohme Corp LLC and Regeneron Pharmaceuticals, Inc.
Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
All Times Listed are for the Eastern Standard Time Zone
Thursday, October 24, 2024 | |
11:00am | Welcome, Introductions, & CE Housekeeping |
11:15am | (01) Biomarker Testing: Understanding The How, Benefits, and Translating to Patient Care » Anthony J. Olszanski, RPh, MD - Vice-Chair, Department of Hematology/Oncology Director, Phase 1 Developmental Therapeutics Program Director, Medical Oncology Melanoma Program Fox Chase Cancer Center |
11:45am | (02) Patience and Understanding: Palliative Care for the APP » Alicia M. Rigby, MSN, RN, APRN, AOCNP - Nurse Practitioner University of California, Davis |
12:45pm | Stump the Faculty - Panel Q&A Discussion |
1:00pm | Meet-the-Clinician Break |
1:15pm | (03) Pain Management: An Integral Component of Caring for the Oncology Patient » Tanya Uritsky, PharmD, BCPP - Opioid Stewardship Coordinator University of Pennsylvania |
2:15pm | (04) What is Chemotherapy » Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP - Clinical Oncology Pharmacist University of Illinois College of Pharmacy |
3:15pm | Stump the Faculty - Panel Q&A Discussion |
3:30pm | Meet-the-Clinician Break |
3:45pm | (05) Treating Melanoma in 2024: The Age of Immunotherapy and Targeted Therapy » Suzanne McGettigan, CRNP - Nurse Practitioner Perelman Center for Advanced Medicine, Abramson Cancer Center |
4:15pm | (06) Identification and Management of Immune Related Adverse Events » Marianne Davies, DNP, ACNP, AOCNP, FAAN - Associate Professor Yale University Yale School of Nursing Oncology Nurse Practitioner-Thoracic & Solid Tumor Senior Advanced Practice Provider II Smilow Cancer Hospital at Yale-New Haven Yale Comprehensive Cancer Center |
4:45pm | (07) Deciphering Radiation Oncology: A Deeper Dive into Acute and Late Effects from Treatment » Bridgett Harr, CNP - Nurse Practitioner Cleveland Clinic |
5:45pm | Stump the Faculty - Panel Q&A Discussion |
6:00pm | Adjourn |
Friday, October 25, 2024 | |
7:55am | Welcome, Introductions, & CE Housekeeping |
8:00am | (08) Neuro-Oncology for the APP: What is Going on Up There? » Vanessa Nevins, PA-C, RDMS, RT - Oncology Physician Assistant, Yale New Haven Smilow Cancer Hospital |
8:30am | Stump the Faculty - Panel Q&A Discussion |
8:45am | Meet-the-Clinician Break |
9:00am | (09) Breast Oncology: Awareness and Current Knowledge » Kayla Freeman, DNP, APRN, FNP-C - Breast Oncology Nurse Practitiner, Emory Winship Cancer Institute |
10:00am | (10) Gynecologic Malignancies: Clinical Pearls » Rachel Frankenthal, PA-C - Gynecologic Oncologic Physician Associate UCLA Health |
10:30am | Stump the Faculty - Panel Q&A Discussion |
10:45am | (11) Lung Cancer: Updates and Advancements » Beth Sandy, MSN, CRNP - Nurse Practitioner, Thoracic Medical Oncology Abramson Cancer Center, University of Pennsylvania |
11:45am | Lunch Break |
12:15pm | (12) Updates in Treating and Managing Patients with Prostate, Bladder and Renal Cell Carcinoma » Brenda Martone, MSN, ANP-BC, AOCNP - Adult Nurse Practitioner Northwestern Medicine » Laura S. Wood, RN, MSN, OCN - Cleveland Clinic |
1:30pm | Stump the Faculty - Panel Q&A Discussion |
1:45pm | Meet-the-Clinician Break |
2:00pm | (13) Head and Neck Cancer: Diagnosis, Staging, and Management » Kristin M. Daly, MSN, ANP-BC, AOCNP - Medical Oncology Siteman Cancer Center Washington University, St. Louis School of Medicine |
3:00pm | (14) Colorectal: Current and Emerging Therapies » Sujata Kane, MS, RD, PA-C - Physician Assistant Winship Cancer Institute, Emory University |
4:00pm | Break |
4:10pm | (15) Hepatic and Pancreatic » Katie L. Green, CRNP, MSN - Nurse Practitioner, Medical Oncology Abramson Cancer Center, University of Pennsylvania » Taylor Aldridge, MMS, PA-C - Physician Assistant, Division of Surgical Oncology, Hepatobiliary and Pancreatic Surgery Stanford University |
5:10pm | (16) Gastric » Sujata Kane, MS, RD, PA-C - Physician Assistant Winship Cancer Institute, Emory University |
5:40pm | Stump the Faculty - Panel Q&A Discussion |
5:55pm | Adjourn |
Saturday, October 26, 2024 | |
7:55am | Welcome, Introductions, & CE Housekeeping |
8:00am |
(17) A Deep Dive into Multiple Myeloma » Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN - Nurse Practitioner Department of Hematology and Medical Oncology Cleveland Clinic » Donna Catamero, ANP-BC, OCN, CCRC - Associate Director of Myeloma Research Icahn School of Medicine at Mount Sinai Hospital New York, NY |
9:00am | Stump the Faculty - Panel Q&A Discussion |
9:15am | (18) Advances in CLL for the Clinical Oncology APP » Lisa Nodzon PhD, APRN, AOCNP - Advanced Registered Nurse Practitioner Moffitt Cancer Center |
9:45am | (19) Follicular Lymphoma for the Clinical Oncology APP » Amy Goodrich, RN, MSN, CRNP - Nurse Practitioner Johns Hopkins |
10:15am | Stump the Faculty - Panel Q&A Discussion |
10:30am | Meet-the-Clinician Break |
10:50am | (20) Understanding and Managing Acute Leukemia, Myelodysplastic Syndrome, and Myelofibrosis » Jennie M. Goble, PA-C - Physician Assistant Mayo Clinic |
11:50am | Lunch Break |
12:20pm |
(21) Benign Heme » Peter Hakos, PA-C - Cleveland Clinic » Lauren Imboden, PA-C - Atrium Health Wake Forest Baptist |
1:20pm | (22) An Update of Current Treatment Options for Patients with Diffuse Large B-Cell Lymphoma » Amitkumar Mehta, MD - Associate Professor of Medicine, Director of Lymphoma, CAR-T Cell Therapy Program University of Alabama |
2:20pm | (23) Sexuality » Anne Katz, PhD, RN, FAAN - AASECT-Certified Sexuality Counselor CancerCare Manitoba |
3:20pm | Stump the Faculty - Panel Q&A Discussion |
3:35pm | Adjourn |
Available Credit
- 15.25 AMA PRA Category 1 Credit™Horizon CME designates this Live activity for a maximum of 15.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 15.25 ANCCThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 15.25 credit.
- 2.25 PharmacologyThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 2.25 credit.
Price
Required Hardware/software
Access to the internet is required.
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
How to obtain credit for attendance (eligibility requirement and process for obtaining certificate)
To receive documentation of credit, participants must:
Login to the educational portal
Attend the educational activity
Complete the post test and online evaluation form.
Attest to the number of hours in attendance in order to generate your certificate
*Requests from learners to claim credit after the evaluation closes will not be granted